Skip directly to content

Nimenrix™(護腦苗)

NimenrixTM (護腦苗) 為腦膜炎雙球菌4價結合疫苗,針對血清型A、C、W135及Y。6星期大的初生嬰兒已可接種,1歲或以上只需1針,並無年齡上限,可獲得長效保護1-5。護腦苗是香港唯一獲歐洲藥物管理局及香港衛生署核准出售的供初生嬰兒接種的腦膜炎雙球菌4價結合疫苗6-8,更於全球超過60個國家及地區註冊9 ,獲得廣泛認可。而且如曾接種腦膜炎雙球菌多醣疫苗,亦可作為加強劑使用1。保護你的摯愛,立即行動!

參考資料:​

  1. NimenrixTM (Meningococcal group A, C, W-135 and Y conjugate vaccine) Prescribing Information. Pfizer Corporation Hong Kong Limited (Version Dec 2016).
  2. Vesikari T, et al. Human Vaccines & Immunotherapeutic 2016; 12(1): 132-139
  3. Baxter R, et al. The Pediatric Infectious Disease Journal. 2015; 34(11): 1236-1243.
  4. Lee C, et al.  Infect Med. 2002:19(3)
  5. Borja-Tabora et al. BMC Infectious Diseases 2015; 15:409
  6. European Medicines Agency.  Nimenrix Marketing Authorization. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002226/human_med_001548.jsp&mid=WC0b01ac058001d124 . Accessed on 1 Apr  2018
  7. Drug Office. The Department of Health. The Government of the HKSAR. Search Drugs Database. Available at http://www.drugoffice.gov.hk/eps/drug/productDetail/en/pharmaceutical_trade/80426.  Accessed 1 Apr  2018
  8. Meningococcal group A, C, W-135 and Y conjugate vaccines. MIMS.com Hong Kong. Drug Information. Accessed 8 Feb 2018.
  9. Data on file – Global Regulatory System. Pfizer Inc

[PP-NIM-HKG-0008]